Mantis Biotech has made headlines by securing $74 million in seed funding, a significant boost for its groundbreaking digital twin technology designed to revolutionize biomedical research, as enthusiastically stated in the publication.
Funding Round Led by Decibel VC
The funding round, spearheaded by Decibel VC, will enable Mantis Biotech to accelerate its growth through strategic hiring, enhanced marketing efforts, and further technological development. This financial backing is expected to play a crucial role in refining the startup's platform, which aims to create virtual replicas of biological systems for improved research outcomes.
Broader Applications in Healthcare
With the new resources at its disposal, Mantis Biotech is poised to broaden the applications of its technology within the healthcare sector. The company is optimistic about releasing its innovative platform to the public in the near future, potentially transforming how biomedical research is conducted.
In a recent development, Seed, an innovative virtual gardening game, previously announced plans for an NFT launch and airdrops to reward loyal players. This initiative aims to enhance player engagement and create a vibrant community, contrasting with Mantis Biotech's focus on biomedical research. For more details, visit read more.
